XTL Biopharmaceuticals Current Assets

XTL Biopharmaceuticals (XTLB.TA) currently reports a current assets of $170K as of December 2025. That compares with $1.3M in the prior-year period — down 87.6% year over year. Use the charts on this page to explore XTL Biopharmaceuticals's current assets history and peer comparisons.

XTL Biopharmaceuticals's current assets decreased from $1.3M to $170K — a 87.6% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

XTL Biopharmaceuticals reported $170K in current assets as of December 2025. That compares with $1.3M in the prior-year period — down 87.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $170K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for XTL Biopharmaceuticals, and consider following XTLB.TA for alerts when major investors trade the stock.

XTL Biopharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $170K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XTLB.TA with unrelated industries.